These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23683264)

  • 21. Effectiveness, Safety, and Predictors of Response to Botulinum Toxin Type A in Refractory Masticatory Myalgia: A Retrospective Study.
    Khawaja SN; Scrivani SJ; Holland N; Keith DA
    J Oral Maxillofac Surg; 2017 Nov; 75(11):2307-2315. PubMed ID: 29078865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin A for the Treatment of Overactive Bladder.
    Hsieh PF; Chiu HC; Chen KC; Chang CH; Chou EC
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26938559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Botulinum toxin injection for refractory non-neurogenic overactive bladder. Systematic review].
    Henriet B; Roumeguère T
    Rev Med Brux; 2015; 36(1):29-37. PubMed ID: 25856969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous Botulinum Toxin Injection for Post-Thoracotomy Pain Syndrome in Palliative Care: A Case Report.
    Rashid S; Fields AR; Baumrucker SJ
    Am J Hosp Palliat Care; 2018 Mar; 35(3):511-513. PubMed ID: 28641445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of botulinum toxin type a in the relief of Carpal tunnel syndrome: A preliminary experience.
    Tsai CP; Liu CY; Lin KP; Wang KC
    Clin Drug Investig; 2006; 26(9):511-5. PubMed ID: 17163284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Complexity of Pain Management in Patients with Erythromelalgia.
    Patel N; Chen E; Cucchiaro G
    A A Case Rep; 2015 Nov; 5(9):151-3. PubMed ID: 26528699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation-Induced Painful Neurogenic Hypertrophy Treated With Botulinum Toxin A.
    Filippakis A; Ho DT; Small JE; Small KM; Ensrud ER
    J Clin Neuromuscul Dis; 2018 Mar; 19(3):135-137. PubMed ID: 29465614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary erythromelalgia].
    Pereira IA; Pereira RM; Borba EF; Gonçalves CR; Yoshinari NH; Cossermelli W
    Rev Assoc Med Bras (1992); 1992; 38(4):228-30. PubMed ID: 1340383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months.
    Díaz-Llopis IV; Rodríguez-Ruíz CM; Mulet-Perry S; Mondéjar-Gómez FJ; Climent-Barberá JM; Cholbi-Llobel F
    Clin Rehabil; 2012 Jul; 26(7):594-606. PubMed ID: 22144721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.
    Guardiani E; Sadoughi B; Blitzer A; Sirois D
    Laryngoscope; 2014 Feb; 124(2):413-7. PubMed ID: 23818108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, randomized non-inferiority trial of a novel botulinum toxin A processed from the strain CBFC26, compared with onabotulinumtoxin A in the treatment of glabellar lines.
    Kim BJ; Kwon HH; Park SY; Min SU; Yoon JY; Park YM; Seo SH; Ahn JY; Lee HK; Suh DH
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1761-7. PubMed ID: 24593323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain.
    Castiglione A; Bagnato S; Boccagni C; Romano MC; Galardi G
    Arch Phys Med Rehabil; 2011 Jul; 92(7):1034-7. PubMed ID: 21704782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum Toxin A in Treatment of Facial Flushing.
    Eshghi G; Khezrian L; Alirezaei P
    Acta Med Iran; 2016 Jul; 54(7):454-7. PubMed ID: 27424017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Repeated Botulinum Toxin Type A Injections for Spastic Equinus in Children with Cerebral Palsy-A Secondary Analysis of the Randomized Clinical Trial.
    Hong BY; Chang HJ; Lee SJ; Lee S; Park JH; Kwon JY
    Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28825663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain.
    Han ZA; Song DH; Chung ME
    Spinal Cord; 2014 Jun; 52 Suppl 1():S5-6. PubMed ID: 24902645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder.
    Giannantoni A; Conte A; Proietti S; Giovannozzi S; Rossi A; Fabbrini G; Porena M; Berardelli A
    J Urol; 2011 Sep; 186(3):960-4. PubMed ID: 21791351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie J; Wilson DI; Herbison GP; Wilson D
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.